Ischemia-reperfusion injury, ischemic postconditioning, hypoxic postconditioning, molecular hydrogen, antioxidants https://mc06.manuscriptcentral.com/cjpp-pubs 
Introduction
The strategies that may improve prognosis of patients after infarction or cardiosurgical interventions are intensively studied. Ischemic preconditioning (IP) induced by short-term ischemic periods has been shown to enhance heart resistance against sustained long-term ischemia/reperfusion injury (Murry et al. 1986 ). Clinical studies have also revealed that patients with unstable angina pectoris (UAP) had better prognosis of subsequent acute myocardial infarction (AMI) than patients without UAP (Papadopoulos et al. 2011) .
Therefore, UAP is considered as a clinical analogue of IP (Papadopoulos et al. 2011; Švorc et al. 2003) . Morever, IP applied prior to percutaneous coronary interventions improves its outcome as well as prognosis of patients with heart transplantation (Hausenloy and Yellon 2016). However, the major limitation concerning clinical application of IP emerges from the fact that protection provided by IP is a relatively short-lived phenomenon. Hence, to reduce infarct size, IP would have to be performed just before an unpredictable AMI. Therefore, a strategy that can modify reperfusion-induced adverse events by brief reperfusionreocclusion periods after long-term ischemia, termed as ischemic postconditioning (IpostC), may have a better potential to be used in AMI management (Vinten-Johansen et al. 2005a) . A beneficial effect of postconditioning has also been demonstrated on cultured cardiomyocytes exposed to long-term hypoxia, when brief episodes of reoxygenation (HpostC -hypoxic postconditioning) led to an improved cell survival following persistent reoxygenation.
Morever, administration of urea as an antioxidant during a HpostC protocol even further amplified protection conferred by HpostC against generation of the strong oxidant peroxynitrite (ONOO -) and enhanced cell viability during reoxygenation (Wang et al. 2006 ).
D r a f t 4
Antioxidant therapy attenuates the damaging effects of reoxygenation-induced free radical generation but may also abrogate cell signaling and redox metabolic reactions (Poljsak et al. 2013 (Slezák et al. 2016) . Although H 2 is not physiologicaly present in metabolism, it has a potential to be applied as a gas for inhalation or dissolved in a drinking water in therapeutical strategies against cardiovascular, cerebrovascular, oncological, metabolic and respiratory disorders (Dixon et al. 2013 ). A recommended concentration of H 2 in pharmaceutical products ranges from 0.8 to 0.4 mmol/l. However, it was shown that drinking of water with ten times lower concentration of H 2 from 0.08 to 0.04 mmol/l was also effective in neurological and metabolic disorders (Ohta et al. 2011 ). H 2 is extremely unique due to its capability to act at the cellular level, to enter the mitochondria and even to translocate to the nucleus (Hong et al. 2010 ). It has been described that H 2 regulates gene expression by supressing the autooxidation of phospholipid mediators in Ca 2+ mediated cell signaling (Iuchi et al. 2016) . Due to this mechanism the hydrogen affects activity of MAP kinases, Ca 2+ /calmodulin-dependent protein kinase (CaMK), prosurvival phosphaidylinositol-3-kinase (PI3K)/protein kinase B (PI3K/Akt) cascade, and expression of myeloperoxidase, caspase-3, 12, Bcl-2 like proteins, cytokines and tumor necrosis factor-α. (Adameová et al. 2012; Ravingerová et al. 2003; Slezák et al. 2016) . Therefore, besides its antioxidant properties, H 2 D r a f t 5 exerts anti-apoptotic, anti-inflammatory, and cytoprotective actions and prevents pathological processes such as necrosis, apoptosis and heart failure (Dixon et al. 2013 ).
This study was designed to evaluate the cardioprotective potential of H 2 in isolated rat hearts perfused according to Langendorff and the capability of H 2 to potentiate the beneficial effect of HpostC. The heart resistance to I/R injury was assessed based on the determination of the size of infarction, recovery of left ventricular function and occurrence of reperfusioninduced malignant ventricular arrhythmias. and coronary flow were used to assess heart function using Power-Lab/85P Chart 7 software (ADInstruments, Germany).
Material and Methods

Animals and ethical approval
Treatment with hydrogen
The hydrogen treatment of isolated hearts was performed using perfusion with KHB saturated with H 2 . The hydrogen was dissolved in O2 and CO2-free KHB (pH corrected to 7.4 by HCl)
under high pressure (40 bar) to a supersaturated level using an apparatus developed by our department. The hydrogen-enriched KHB (H 2 -KHB) was prepared every third day and stored at atmospheric pressure at 8˚C in aluminium flasks with no dead volume to prevent the reaction of H 2 with atmospheric O 2 . H 2 can be applied in hypoxic conditions only because of H 2 reaction with O 2 . Therefore, the hypoxic postconditioning had to be designed in a setting of hydrogen administration. After administration of hydrogen to hypoxic buffer pH was 7.8, which then was corrected by HCl to 7.4. The hydrogen-enriched KHB was warmed to 37˚C
and heating of solution did not change its pH. H 2 concentration was measured by titration using metylene blue and colloidal platinum according to Seo et al. (2012) immediately prior to using H 2 -KHB in heart perfusion. The concentration of hydrogen in H 2 -KHB was not lower
Experimental protocols
The number of animals per group was 8-10. The isolated hearts in all groups were allowed to stabilise (20 min) before further interventions. Schemes of experimental protocols are shown in Fig. 1 .
1. In the control group (C), after a stabilisation period, hearts were exposed to 30-min global zero-flow ischemia followed by 120-min restoration of perfusion (reperfusion).
During the whole protocol of ischemia/reperfusion, except the ischemic period, the hearts of this group were perfused with a standard KHB saturated with O 2 and CO 2 .
2. Hypoxic postconditioning (HpostC) was induced immediately after ischemia, by four cycles of 1-min perfusion with oxygen-free KHB (hypoxia) intercepted by 1-min perfusion with a standard O 2 and CO 2 saturated KHB. That was followed by 120 minreperfusion like in protocol 1.
3. Hydrogen treatment was applied in a setting of hypoxic postconditioning (H 2 +HpostC) in a similar manner like HpostC, however, O 2 and CO 2 -free KHB was saturated with H 2 .
Determination of infarct size
The infarct size was determined according to Ravingerová et al. (2009) . Briefly, after 120-min reperfusion, hearts were perfused with 1% 2,3,5 triphenyltetrazolium chloride (TTC, Sigma, USA) dissolved in 0.1mol/l phosphate buffer (pH 7.4) to stain the surviving myocardium in the whole left ventricle. Stained hearts were incubated in phosphate buffer for 30 min at 37˚C than stored overnight in 10% formaldehyde. The hearts were then cut perpendicularly to the long axis of the ventricle into slices 1-2 mm thick and residues of right ventricles were removed. Both sides of slices were subsequently photographed, and non-stained infarcted area
representing infarct size (IS) within the whole risk area (AR) in LV slices was evaluated using non-commercial planimetric software. The IS was normalised to the AR (IS/AR).
Evaluation of reperfusion-induced arrhythmias
The electrogram recording was used for the measurement of reperfusion arrhytmias, such as the total number of extrasystoles (ES), number of episodes and total duration of ventricular tachycardia (VTE and VTD, respectively), number of episodes and total duration of ventricular fibrillation (VFE and VFD, respectively). Arrhythmias severity was evaluated using an arrhytmia score calculated in accordance with the presence of the most severe form of arrhytmias in each individual heart and used for a group analysis (Curtis and Hearse 1989). 
Results
Characteristics of isolated hearts
The baseline preischemic values of heart rate, LVSP, LVEDP, LVDP, +/-(dP/dt) max , and coronary flow in all groups of isolated hearts prior to further interventions are summarized in Table 1 . There were no significant differences in baseline hemodynamic parameters between the groups.
Size of myocardial infarction
As shown in Fig. 2 , both hypoxic postconditioning and hydrogen treatment in a setting of hypoxic postconditioning significantly reduced IS/AR in comparision with infarct size in nonpostconditioned controls (24.6 ± 0.9% and 16.7 ± 0.8%, respectively, vs. 38.7 ± 1.4% in controls; p˂0.05). Moreover, hydrogen treatment significantly decreased IS/AR compared to infarct size in postconditioned hearts that were not subjected to hydrogen treatment (16.7 ± 0.8% vs. 24.6 ± 0.9%, p˂0.05).
Post-I/R parameters of LV function
The timecourse of post-I/R recovery of systolic function expressed as % of the baseline values of LVDP is shown in Fig. 3A , and the development of diastolic dysfunction manifested as changes in end-diastolic pressure (LVEDP) during reperfusion is shown in Fig. 3B . Recovery of LVDP at 40 min of reperfusion was higher than in the controls in both postconditioned groups (Fig. 3A) . However, LVDP was significantly improved only in the H2-enriched postconditioned group (H 2 +HpostC: 62 ± 12% vs. 23 ± 3.6% in controls; p˂0.05). In addition, LVDP recovery was significantly improved in H 2 +HpostC group vs. controls (p˂0.05) D r a f t 10 starting at the 5th min of sustained reperfusion with O 2 -rich KHB (Fig. 3A) . LVEDP was significantly decreased in both conditioned groups to a similar level (HpostC: 22.0 ± 6.0 mmHg, H 2 +HpostC: 28.6 ± 5.8 mmHg vs. 54.7 ± 7.2 mmHg in controls, both p˂0.05, Fig.   3B ).
HpostC also significantly improved post-I/R recovery of -(dP/dt) max (62 ± 13 vs. 28 ± 2.9; p˂0.05) as the index of relaxation (Fig. 4B) . Similarly, restoration of coronary flow expressed as % of preischemic values was significantly higher in the HpostC group than in the controls (86 ± 11% vs. 57 ± 12%; p˂0.05) (Fig. 5) . Presence of H 2 significantly improved recovery of +(dP/dt) max (index of contraction, 56.4 ± 9.3% vs. 26 ± 2.6%; p˂0.05) and further increased -(dP/dt) max recovery (78 ± 4.5% vs. 28.2 ± 2.9; p˂0.01) (Fig. 4B) , as well as restored coronary flow to its preischemic values (102 ± 16% vs. 57 ± 12% in the controls;
p˂0.01) (Fig. 5) .
Reperfusion arrhythmias
Differences in parameters of reperfusion-induced arrhythmias between both postconditioned groups and controls are summarized in Table 2 . However, not all of them reached the levels of statistical significance. Nevertheless, the number of VT episodes in HpostC group was significantly decreased as compared with VTE in controls (3.3 ± 1.5 vs. 19.8 ± 6.9).
Moreover, the incidence of the most severe form of arrhythmias, VF, was lower in HpostC group and further decreased in H2+HpostC group (17% vs. 58% in controls). In addition, VF duration was significantly reduced only in the H 2 +HpostC group as compared to that in nonconditioned controls (p˂0.05). Accordingly, the overall severity of arrhythmias in H2+HpostC group as assessed by arrhythmia score was significantly lower than in the controls (p˂0.05).
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Discussion
In this study, we demonstrated that hypoxic postconditioning improves heart resistance to I/R lethal injury, post-ischemic recovery of heart function and attenuates post-I/R arrhytmias, similar to ischemic pre-or postconditioning. The experimental results showed smaller infarcts ( Fig. 2. A,B) , and better post-I/R recovery of functional parameters -LVDP, LVEDP (Fig. 3. A,B), rate of relaxation [-(dP/dt) max ] (Fig 4. B) and coronary flow (Fig. 5) . HpostC also decreased the number of episodes of ventricular tachycardia (Table. 2). The short-term hypoxic stress after prolonged ischemia as a therapeutic strategy has a higher potential to be used in clinical practice than IP. This is because although the acute myocardial infarction may be indeed foreseen, it always occurs unexpectedly. Morever, it seems that intervention by brief hypoxic episodes has some advantages over brief ischemia. It has been observed that IpostC-induced antiinfarct protection may be effective when the algorithm of brief R/I cycles takes from 10 to 30 sec (30 sec reperfusion + 30 sec reischemia) whereas the 1-min algorithm is ineffective (Vinten-Johansen et al. 2005b ). However, HpostC was also protective in cultured myocytes using a longer (5-min) algorithm of reoxygenation/rehypoxic cycles and improved cell survival during subsequent sustained reoxygenation (Wang et al. 2006) .
Similarly, a 3-min algorithm of hypoxic reperfusion effectively improved recovery of heart function and suppressed oxidative injury during oxygen restoration in a setting of Langendorff perfusion (Serviddio et al. 2005 ). An algorithm of a longer period of conditioning with preserved coronary flow may also allow a prolonged pharmacological cointervention with brief hypoxic cycles, e.g., using heart perfusion with cardioplegic solutions in a heart-lung apparatus. induced by brief ischemia-reperfusion or hypoxia-reoxygenation cycles reduces oxidative stress and lipid peroxidation during recovery of oxygen supply (Sun et al. 2005 (Sovari 2016) . Therefore, HpostC might probably prevent Ca 2+ overload observed in cardiomyocyte cultures (Sun et al. 2005) and improve recovery of functional parameters in isolated perfused hearts during prolonged reoxygenation (Serviddio et al. 2005) . This antioxidant efficacy is involved in a passive PostC-mechanism based on gradual recovery of oxygen supply, which does not depend on cell signalling (Vinten-Johansen et al. 2005b ).
However, there are discrepances with respect to the additive effect of antioxidants co- Therefore, H 2 is considered as a selective antioxidant (Hong et al. 2010) . Hence, H 2 coadministration is not supposed to impair cell signaling induced by postconditioning. On the other hand, in our experiments, H 2 co-administration even potentiated the antiinfarct effect of HpostC (Fig. 2) , and enhanced postischemic recovery of LVDP to the levels of statistical significance starting at the 5th and 10th min of oxygen-rich reperfusion (Fig. 3A) , when ROS production reaches the highest levels (Ferrari et al. 1991) . At the same time period, which is considered as critical with regards to occurrence of malignant ventricular arrhythmias associated with increased ROS production (Sovari 2016) , H 2 treatment resulted in a significant attenuation of severity of arrhythmias (Table 2) . Furthermore, in the 40th min of the oxygen-rich reperfusion, recovery of LVDP was improved to the levels of statistical significance (Fig. 3A) coupled with significantly better recovery of contraction and relaxation rates (Fig. 4A,B) , while coronary flow was restored to the preischemic values ( Preservation of physiological ROS production with regards to metabolism and cell signaling, is the advantage of molecular hydrogen over other antioxidants (vitamin C, tetrakis-4-sulphonatophenyl-porphyrinato iron) which may blunt antiinfarct and antistunning effects of pre-or postconditioning (Li et al. 2013; Tsolvas et al. 2008) . Therefore, hydrogen treatment may have a potential to be applied in a clinical practice to improve prognosis of the patients in reconvalescence after infarction or larger cardiosurgical interventions using heart-lung apparatus as well as after heart transplantation.
Conclusion
Application of molecular hydrogen appears to be beneficial in a setting hypoxic postconditioning by strengthening its cardioprotective efficiency. Potential mechanisms behind this effect might be related to the antioxidative effects of HpostC and its enhancement by hydrogen treatment. However, molecular mechanisms underlying the protective effects of hydrogen treatment remain to be elucidated.
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